T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
851
DELISTED
St Jude Medical
STJ
| $47.7M | 0.01% |
733,727
-1,350,980
| -65% | -$87M |
|
852
Cohen & Steers
CNS
$4.36B
| $47.6M | 0.01% |
1,132,290
+7,200
| +0.6% | +$301K |
|
|
HTS
853
DELISTED
HATTERAS FINANCIAL CORP
HTS
| $47.5M | 0.01% |
2,578,920
+845,710
| +49% | +$16M |
|
854
Sonida Senior Living
SNDA
$1.88B
| $47.5M | 0.01% |
127,031
-9,481
| -7% | -$3.34M |
|
855
Petrobras
PBR
$114B
| $47.4M | 0.01% |
6,492,802
-513,435
| -7% | -$5.53M |
|
856
Zions Bancorporation
ZION
$10.5B
| $47.4M | 0.01% |
1,661,001
-326,180
| -16% | -$9.2M |
|
857
Check Point Software Technologies
CHKP
$13.2B
| $47.3M | 0.01% |
602,000
-469,100
| -44% | -$34.9M |
|
|
MJN
858
DELISTED
Mead Johnson Nutrition Company
MJN
| $47.2M | 0.01% |
469,372
+11,810
| +3% | +$1.18M |
|
|
AEGN
859
DELISTED
Aegion Corp
AEGN
| $47.1M | 0.01% |
2,530,810
-19,300
| -0.8% | -$357K |
|
860
Equinix
EQIX
$105B
| $47.1M | 0.01% |
207,710
+5,999
| +3% | +$1.3M |
|
861
Fomento Económico Mexicano
FMX
$40B
| $46.9M | 0.01% |
532,500
+4,450
| +0.8% | +$408K |
|
862
Wayfair
W
$14.1B
| $46.3M | 0.01% |
+2,407,598
| New | +$57.8M |
|
|
NATL
863
DELISTED
National Interstate Corporation
NATL
| $46.3M | 0.01% |
1,552,180
-13,800
| -0.9% | -$395K |
|
864
Washington Trust Bancorp
WASH
$750M
| $46.2M | 0.01% |
1,148,736
-141,544
| -11% | -$5.22M |
|
|
CTRL
865
DELISTED
Control4 Corporation
CTRL
| $46M | 0.01% |
2,994,662
-18,640
| -0.6% | -$268K |
|
866
Ethan Allen Interiors
ETD
$575M
| $45.8M | 0.01% |
1,480,410
-332,576
| -18% | -$9.28M |
|
|
RLD
867
DELISTED
REALD INC COM STK
RLD
| $45.8M | 0.01% |
3,877,600
-17,500
| -0.4% | -$198K |
|
868
Valero Energy
VLO
$95.1B
| $45.7M | 0.01% |
922,934
-8,296
| -0.9% | -$402K |
|
869
Brown-Forman Class B
BF.B
$12.8B
| $45.6M | 0.01% |
1,621,194
-105,312
| -6% | -$3.05M |
|
|
GEVA
870
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $45.5M | 0.01% |
490,700
+484,100
| +7,335% | +$38.2M |
|
|
CTT
871
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $45.5M | 0.01% |
4,019,800
+413,480
| +11% | +$4.6M |
|
|
CERN
872
DELISTED
Cerner Corp
CERN
| $45.5M | 0.01% |
703,385
+19,363
| +3% | +$1.2M |
|
873
Synaptics
SYNA
$4.3B
| $45.4M | 0.01% |
659,215
-178,400
| -21% | -$11.9M |
|
874
Methode Electronics
MEI
$602M
| $45.3M | 0.01% |
1,240,370
-1,039,550
| -46% | -$39M |
|
|
MWIV
875
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $45.2M | 0.01% |
266,300
+700
| +0.3% | +$112K |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.